Zai Lab Ltd is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.

Biotechnology

Zai Lab

This department focuses on scientific research and innovation to develop new products and technologies.

Research and Development

The R&D and Scientific Research Team at Zai Lab is dedicated to advancing the company's biopharmaceutical pipeline through rigorous scientific exploration and innovation. Comprising experts in various domains, the team focuses on the discovery and development of new therapeutics, particularly in oncology and other critical therapeutic areas. They conduct research, oversee clinical trials, and ensure compliance with regulatory standards, ultimately striving to bring novel treatments to patients with unmet medical needs in the Chinese market and beyond.

R&D and Scientific Research Team

The Clinical Operations Team at Zai Lab is responsible for overseeing the planning, execution, and management of clinical trials for the company’s diverse pipeline of therapeutic candidates. This team collaborates with cross-functional partners to ensure that studies are conducted efficiently, comply with regulatory standards, and meet timelines, ultimately supporting the development of innovative treatments in oncology, autoimmune, and infectious diseases for the China market.

Clinical Operations Team

The Leadership Team at Zai Lab plays a pivotal role in guiding the company’s strategic vision and operations within the biopharmaceutical landscape. Comprising executives with expertise in compliance, legal affairs, medical research, clinical operations, and business development, this team is responsible for overseeing the development and commercialization of innovative therapeutics, ensuring regulatory compliance, and fostering partnerships that enhance Zai Lab’s pipeline in oncology, autoimmune, and infectious diseases. They collectively drive decision-making processes that align with the company's mission to address critical medical needs in the China market and beyond.

Leadership Team

This department provides strategic direction and oversight to ensure organizational goals are met.

Leadership Council

The Medical Affairs and Clinical Development team at Zai Lab plays a crucial role in advancing the company's biopharmaceutical pipeline by overseeing clinical trial design, execution, and regulatory submissions for drug candidates in the fields of oncology and autoimmune diseases. This multidisciplinary team collaborates closely with research and development, ensuring effective communication of data and insights, and is responsible for strategic medical affairs activities, including education and stakeholder engagement, to support the commercial strategies for both greater China and global markets.

Medical Affairs and Clinical Development

The Finance and Procurement team at Zai Lab plays a critical role in managing the financial health and operational efficiency of the company. This team oversees budgeting, financial planning, and corporate finance activities to ensure effective resource allocation for drug development and commercialization. In addition, they handle procurement strategies to optimize sourcing and supply chain management, ensuring that the organization secures necessary materials and services to support its innovative biopharmaceutical pipeline.

People (5)

Jobs (0)

Other teams

R&D and Scientific Research Team

Clinical Operations Team

Leadership Team

Leadership Council

Medical Affairs and Clinical Development

Finance and Procurement